About this event
UNPRECEDENTED: Industrial Dialogues
Expoquimia BIO: Vaccines: Research, technology, manufacturing and access
In this webinar we will cover topics related to the complete value chain in the development of a vaccine and its adoption: from the research on the infection typology and the identification of the vaccinal candidates, the available technologies for its production, the manufacturing processes at an industrial scale and its distribution to guarantee a universal access to vaccines, taking also into account the regulatory aspects.
The Covid-19 pandemic has notably accelerated several of these development stages, allowing the development of these vaccines in a shorter period of time, and, once more, putting the spotlight on the relevance of vaccines to protect our communities against emerging infectious diseases.
Update on COVID-19 vaccines: what do we know?
Dra. Júlia Vergara Alert, Coronavirus Group Main Researcher, Institute of Agrifood Research and Technology (CReSA-IRTA)
Dr. Philippe-Alexandre Gilbert, Senior Program Officer CMC, Bill and Melinda Gates Foundation
Regulatory Aspects of Vaccines
Dra. Sol Ruiz Antúnez, Head of Biologics, Biotechnology and Advanced Therapies, Spanish Medicines Agency (AEMPS)
Dra. Margarita del Val, Chemist, Virologist, Inmunologist and Scientific Researcher at Center for Molecular Biology "Severo Ochoa" at Consejo Superior de Investigaciones Cientificas (CSIC)
Vaccines, Industrial Manufacturing
Adolfo López, Production and Maintenance Manager at Laboratorios Zendal
Dr. Francesc Gòdia, Professor at Department of Chemical Enginering, Universitat Autónoma de Catalunya and President of Banc de Sang i Teixits de Catalunya (BST)
UNPRECEDENTED Webinar Series sheds a light on the transformational challenges related to Circular Economy, Digitization and Tech Transfer.
Together we have designed a series of online activities named Industrial Dialogues, aimed towards showcasing examples and solutions on how the sector will be able to overcome the challenges ahead.
This content is part of:
An initiative of:
Dra. Ruiz has a PhD in Biology (Immunology), chair of the BWP (Biologics Working Party) at the EMA (European Medicines Agency) since March 2014 and member of the CAT (Committee for Advanced Therapies) and a co-opted member of the CHMP (Committee for Human Medicinal Products) also at the EMA.
Phd in Chemical Sciences (Biochemistry and Molecular Biology) at UAM. Scientific Researcher and Coordinator of the Indisciplinar Platform on Global Health at CSIC. Representative for Spain at EMA. Member of the Royal National Academy of Pharmaceutics and of the Expert Advisory Committee of the Autonomous Region of Madrid.
Dr. Gilbert was, just recently, responsible for the development of the Next Generation Flu vaccine at Sanofi Pasteur. Has led task forces on the development of vaccines for HIV, RSV, CMV, SARS, Influenza and COVID. He joined the VDS group at the Gates Foundation as Senior Program Officer CMC.
Adolfo is a biologist and Master of Biotech Engineering from the Santiago de Compostela Uni. He has a large experience in biological Production. From 2010 he is Production Director at CZ Vaccines, S.A. and, from 2015 he is Production and Maintenance Manager at CZ Vaccines, S.A. at Zendal Labs from.
Júlia did her PhD on Medicine and Animal Health at the UAB (2012). She moved to Germany and worked at the Institute of Virology in Marburg as postdoc researcher. In 2015, she came back to Barcelona and worked at IRTA-CReSA where she is the main investigator of the coronavirus research line.
Fira de Barcelona is one of the most important trade fair organisations in Europe. Discover all the information about the upcoming events.
Share this event